ERBB2 and cancer: In contrast, lysosomal delivery of ErbB2 upon treatment of ErbB2+ cancer cell lines with Trast is distinctly slower and incomplete [32, 33], apparently due to the maintenance of a recycling itinerary of Trast-bound ErbB2 [53].